Valiant Laboratories Board Meeting Scheduled for 2nd Nov'26 to Consider Q2 Results
Valiant Laboratories Ltd 路 Intimation 路 02 Nov 2026, 5:30 am
Valiant Laboratories Board Meeting Scheduled for 2nd Nov'26 to Consider Q2 Results Valiant Laboratories Limited announced that its Board of Directors will meet on 2nd Nov'26 to consider and approve the standalone and consolidated audited financial results for the quarter and half year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the company's trading window for dealing in its securities, which has been closed since 29th Sep'26, will remain closed until 4th Nov'26.
Original exchange filing (PDF)
More announcements from Valiant Laboratories Ltd
- Intimation of sad demise of the member of a Promoter Group of the Company 路 16 Nov 2026
- Audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Valiant Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 03 Nov 2026
- Valiant Laboratories Limited has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Quarterly ended September 2026 . 路 02 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 02 Nov 2026
- Scrutinizer''s Report and Voting Results of 5th AGM of Valiant Laboratories Limited. 路 29 Sept 2026
- Scrutinizer''s Report and Voting Results of 5th AGM of Valiant Laboratories Limited. 路 29 Sept 2026
